Predictive readmission risk is a useful signal only if operations translate it into timely, prioritized follow-up. Scores alone do not reduce returns to acute care. What matters is the set of downstream processes that turn a high-risk flag into a short, effective intervention: targeted calls,…
Patient-reported outcomes (PRO) sit at the center of many modern trial endpoints, and when those data are messy the study’s conclusions become harder to defend. FDA advisory committees have recently questioned the interpretability of pivotal oncology data sets where PRO collection was inconsistent or where…
When patients prefer treatment paths that require more frequent follow-up, the operational burden shifts from surgeons and oncologists to the everyday work of scheduling, reminders, and monitoring. Patient-reported outcome (PRO) collection and patient engagement workflows are the tools that let clinics manage per-patient timelines at…
Scaling screening and follow-up for the mental health of older adults is an operational problem, not just a clinical one. As populations age, more people experience depression, anxiety, loneliness, and abuse that go unrecognized. Recent guidance from the World Health Organization underscores the scope of…
Clinical trial recruitment lives and dies on per-person timelines. Each potential participant has a screening window, a consent date, a visit schedule, and a follow-up cadence that belongs to them alone. When research site networks merge (a U.S. consolidation combining sites across several states was…
Improving the patient experience is often less about slogans and more about the small, repeatable handoffs that happen before, during, and after an appointment. When teams promise follow-up, deliver visit summaries, or ask patients to monitor symptoms, the operational question is simple: who owns the…